Blog - Page 987 of 5701 - QualityStocks

FridayMay 06, 2022 9:00 am

Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial

Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause of mental disability worldwide Preclinical studies show CYB003 may have significant advantages over classic psilocybin In a significant step forward in the study of alternative treatments for major depressive disorder, Cybin (NEO: CYBN) (NYSE American: CYBN) is moving forward in its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003 (https://ibn.fm/VTjoI). Based on previous research, CYB003 has the potential to effectively treat MDD with significant…

FridayMay 06, 2022 9:00 am

Kronos Advanced Technologies Inc. (KNOS) Venturing into Metaverse with Initial eCommerce Virtual Store

“Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article Kronos is one of the earliest companies to design and soon open its own metaverse virtual store Emergen Research reports that metaverse market reached $47.69 billion in 2020, by 2028 could see a revenue CAGR of 43.3% The metaverse is everywhere, popping up in entertainment and vying for news headlines. This immersive virtual world where people live, work, shop and interact through avatars once seemed like science fiction but is fast becoming a real-world fact. Savvy companies, including Kronos Advanced Technologies…

ThursdayMay 05, 2022 3:00 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma multiforme (“GBM”). On average, GBM is nearly 100% fatal just over a year into diagnosis. “CNS announced that France’s regulatory agencies have granted the company authority to pursue patient recruitment in the country…. France’s approval comes on the heels of similar authorization in Switzerland, where Swissmedic, the Swiss agency for therapeutic products, joined swissethics, the umbrella organization of the cantonal Ethics Committees (‘ECs’), in greenlighting…

ThursdayMay 05, 2022 2:42 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Eyeing Expanded Physical Presence, Bolstered Functional Experience

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) CEO Marc Aneed, in a recent business letter, acknowledged how the ongoing COVID-19 pandemic, along with the Russia-Ukraine war, had taken a toll on supply chains but expressed utmost confidence in the company’s teams and partners. “Since its inception in 2020, Eat Well Investment Group has managed to deal with one challenge after another, always coming out on top. This has been evidenced by the company’s uninterrupted expansion moves that have seen the acquisition of Belle Pulses Ltd., Sapientia Technology Inc. and Amara Organic Foods. It is also demonstrated by its accelerated…

ThursdayMay 05, 2022 2:06 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads, “Seven years ago yesterday, on Star Wars Day, Knightscope deployed its first robot at a popular Silicon Valley mall — an expanding use case with proven, ongoing successes. Protecting large parking lots and structures by enhancing existing security operations with a K5 Autonomous Security Robot (‘ASR’) helps to deter common challenges among mall owners and management companies such as trespassers, criminal mischief, and catalytic converter…

ThursdayMay 05, 2022 1:54 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Announces Update on Installation of One of Illinois’ Largest Rooftop Solar Power Facilities

Correlate Infrastructure Partners (OTCQB: CIPI) today announced that final engineering, permitting and interconnection work has begun on the Geneva, Illinois, facility where the company has contracted to install a large-scale rooftop solar project. The massive project is being constructed at the headquarters of Continental Envelope and is located at the company’s manufacturing plant, which has the capacity to produce 2 billion envelopes per year. The clean energy system complements Continental’s “Pushing the Envelope” Community Gardens surrounding the property. “Correlate Infrastructure Partners loves supporting ESG-focused businesses that are making a true difference in their industries and communities. This attractive project makes…

ThursdayMay 05, 2022 1:19 pm

QualityStocksNewsBreaks – SPYR Technologies’ (SPYR) Applied Magix Considers Developing Commercial Software to Support Non-Branded Products

SPYR (OTCQB: SPYR) is a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The company today announced that it is considering developing software for non-branded smart products in order to improve the user experience (“UX”), enhancing available products without the burden of new hardware development. “In our research into viable products to manufacture or carry, we have come across a number of manufacturers in China, with well-engineered, often excellent hardware, yet abysmally poor software. Since the software is the main point of interaction for…

ThursdayMay 05, 2022 12:44 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Featured on Success Story Podcast

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its cofounder and CEO Matt Stang were spotlighted in a recent episode of The Success Story podcast. During the interview, Stang talked all things Delic, including a history of the company, his decision to pivot from a career in cannabis to psychedelics, and what he believes the future holds for the company. “When we created [Delic], it was really under the supposition that a tipping point was coming for psychedelics the way it had come for cannabis,” said Delic Holdings…

ThursdayMay 05, 2022 12:37 pm

The Southeastern Hemp & Medical Cannabis Convention To Promote Operational Success Through Science and Education

Organa Kannalytics LLC invites cannabis businesses, stakeholders, researchers, patients, farmers distributors, and related industries, are all invited to attend the Southeastern Hemp & Medical Cannabis Convention (“SHMCC”) being held from 12-14 March 2022 at the Cobb Galleria Centre, Two Galleria Parkway, Atlanta, Georgia. The SMHCC is being touted as the central meeting point for industry leaders and influencers to come together for networking, discussing medical advancements in the cannabis industry, and discovering new business opportunities. The event offers immense scope to new businesses and organizations to get better market visibility and explore the vast spectrum of possibilities that lay ahead. The…

ThursdayMay 05, 2022 12:32 pm

QualityStocksNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster presentation at the “From Research to Reality” Global Summit on Psychedelic-Assisted Therapies and Medicines. The event is slated to take place from May 27-29, 2022, in Toronto, Canada. “It is an honor to participate in this inaugural conference devoted to psychedelic-assisted therapy and to be part of the rigorous scientific work being done in the field,” said Doug Drysdale, chief executive officer of Cybin. “The…

Site Search

Company Search